Sign inJoin waitlistJoin the waitlist

Osarenren Ogbeide

Associate Professor · University of Tennessee College of Medicine

Credentials: · · · · · · ·

History

University of Tennessee College of Medicine
Present

Hematology and Medical Oncology
University of Tennessee College of Medicine
2014–2017
Internal Medicine
The University of Tennessee Health Science Center
2011–2014
Woodhull Medical and Mental Health Center
1999–2002
University of Benin School of Medicine
1990–1994

Research

Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry
JCO Global Oncology · 2021 · 22 citations
Hand-assisted laparoscopic colectomy compared with open colectomy in a nontertiary care setting
Clinical Colorectal Cancer · 2007 · 5 citations
Managing Massive Splenic Hematoma: Exploratory Laparotomy or Active Surveillance?
Case report · Cureus · 2021 · Last of 4 authors · 4 citations

Raymond Osarogiagbon
4 papers
Steve Otieno
2 papers · 2 as a fellow
AF
Adam Friedant
1 paper
AC
Allison Chang
1 paper · 1 as a fellow
Alva Weir
1 paper
AU
Anna-Carson Uhelski
1 paper · 1 as a resident
AM
Anurag Mehrotra
1 paper
Brandon Mahal
1 paper · 1 as a resident
Daniel George
1 paper
Denise Kent
1 paper
Egunmwendia Ogbeide
1 paper
EH
Elisabeth Heath
1 paper

Clinical trials

Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC
Site PI · Recruiting · Phase 2
H. Lee Moffitt Cancer Center and Research Institute
2025–2030
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2025–2039
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2037
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Site PI · Recruiting · Phase 2
SWOG Cancer Research Network
2024–2028